[P75] Poster Session 75　Hepatobiliary/Pancreatic Cancer（Pancreatic Cancer 2）

[P75-1] Comparison between mFOLFIRINOX and nal-IRI/FL as second-line treatment for unresectable GEM resistant pancreatic cancer

^○Toshifumi Doi¹, Takeshi Ishikawa^1,2, Ryuichi Morita¹, Tomoki Sakakida¹, Seita Kataoka¹, Hayato Miyake¹, Naohisa Yoshida¹, Yoshio Sogame¹, Hiroaki Yasuda¹, Hideyuki Konishi¹, Yoshito Itoh¹ (1.Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, 2.Outpatient Oncology Unit, University Hospital, Kyoto Prefectural University of Medicine)